TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced the completion of the pro2cool®clinical trial.
Nottingham Spirk's Director of Insights Amanda Beacher was recently quoted by Clinical Trials Arena regarding the FDA's new guidance on patient advisors.
Crain's Cleveland Business first published this article about Northeast Ohio's significant role in getting the Sterifre AURA disinfectant system to market.
Nottingham Spirk and CardioInsight developed EC VUE Sensor Array vest, acquired by medical device company Medtronic earlier this year for over $100 million.
